The patient monitoring market is expected to be worth more than $350 billion by 2025, as the focus is likely to move beyond device
sales to solutions, according to a recent Frost & Sullivan's report.
The report, Patient
Monitoring Industry—Analysis of Investment and Trends outlines the
future of patient monitoring across the continuum of care, the shifts in the
market, and investment opportunities.
Evolution of
Patient Monitoring
Patient monitoring has evolved from
Read More
Cardiac Monitoring
Vixiar Medical Nabs $1.5M to Expand Hand-Held Devices for Cardiac Monitoring
Vixiar Medical, Inc., a Baltimore, Maryland-based company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases has raised $1.5 million from new and existing investors. New investors joining in this round included Emerald Development Managers, MMG Opportunities and several individual investors. Existing investors included The Maryland Technology Development Corporation (TEDCO) through its seed fund, the Abell Foundation, individual investors and
Read More
Ochsner to Deliver Remote Monitoring Service to Cardiac Implant Patients Across Southeast
Ochsner Health System announced it will deliver remote monitoring service for patients with cardiac implants will be utilized in the throughout Louisiana, Arkansas, Mississippi, Alabama, and Georgia. The provider has signed an agreement with Geneva Health Solutions (GHS), a device data management platform and remote monitoring service for implantable cardiac devices to provide the service. The GHS system will drive full automated scheduling and reporting in collaboration with Ochsner’s Epic
Read More
AliveCor Receives “Breakthrough Device” Designation from FDA for Bloodless Hyperkalemia Test
AliveCor, a Mountain View, CA-based digital health startup developing solutions to transform cardiac care, announced on Monday received “breakthrough device” designation from the U.S. Food and Drug Administration for their bloodless hyperkalemia test. Developed with Mayo Clinic, AliveCor’s KardiaK Platform screens for elevated levels of blood potassium – hyperkalemia, without requiring any blood from the patient.This designation signals that the FDA will consider the technology on an
Read More
EarlySense Acquires Analytics Score Tool That Predicts Cardiac Arrest Risk
EarlySense, the market leader in contact-free continuous monitoring solutions across the healthcare care continuum, announced today it has signed a deal for exclusive global rights to a cardiac predictive analytic scoring tool. Developed by Dr. Dana Edelson, Executive Medical Director of Rescue Care at the University of Chicago, the eCART ‘Lite’ early warning score tool analyzes heart and respiratory parameters to predict cardiac arrest risk and enable early intervention. Dr. Edelson’s clinical
Read More
Microsoft and Apollo Hospitals to Build AI-Powered Cardiology Network
Apollo Hospitals, India's leading super specialty hospital has inked a partnership with Microsoft to create an AI-powered cardiology network to predict heart disease. The partnership is part of Healthcare NExT, a Microsoft initiative which aims to accelerate healthcare innovation through artificial intelligence and cloud computing.Together, Microsoft and Apollo Hospital will be developing and deploying new machine learning models to gauge patient risk for heart disease in hopes of preventing or
Read More
Biotricity Releases Mobile Cardiac Telemetry Solution
Biotricity today announced the commercial availability of Bioflux, a real-time, high-precision mobile cardiac telemetry solution for customers. The Bioflux system, which received final FDA approval in December, is a complete solution for cardiac monitoring and diagnosis, consisting of the Bioflux device, proprietary software, and a 24/7 monitoring center that merges seamlessly with physicians’ existing platforms and workflows.The Bioflux system is a complete solution for cardiac monitoring and
Read More
Cardiac Monitoring Startup Eko Devices Raises $5M to Bring Intelligence to Heart Sounds
Eko, a San Francisco, CA-based platform of non-invasive cardiac screening devices, care coordination software, and machine learning algorithms has raised $5 million in Series A funding led by ARTIS Ventures. The round also included participation from Strategic Partners, Dreamlt Ventures, 1812 Ventures, and FOUNDER.org. Eko plans to utilize the funding to accelerate its commercial team and to expand clinical studies on the use of Eko's platform for valvular heart disease screening and heart
Read More
Eko Duo Receives FDA Clearance to Market Combined Digital Stethoscope/ECG Smart Device
Eko Devices, a provider of mobile acoustic cardiac monitoring solutions has received FDA clearance to market its latest solution, Eko Duo, a smart heart monitor transforming how patients and their physicians monitor heart disease. Eko Duo combines the digital stethoscope and ECG for monitoring patients in the clinic or at home into a compact, handheld device.The DUO, which patients can obtain with a prescription, can seamlessly stream cardiac data (stethoscope + ECG) to specialists, providing
Read More
